Public Company News

Stephanie Dinkins Named Inaugural Recipient of the LG Guggenheim Award

* The trailblazing Brooklyn-based artist, educator, and artificial intelligence practitioner aims to create equitable social and technological ecosystems. * The Award is part of the LG Guggenheim Art and Technology Initiative, a five-year, multifaceted collaboration designed to research, hono...

2023-05-20 01:51 4834

Fresh2 Group Ltd. Announces Nasdaq Ticker Symbol Change from 'ANPC' to 'FRES'

Ticker symbol change effective at the market open May 22, 2023 NEW YORK, May 19, 2023 /PRNewswire/ -- Fresh2 Group Ltd., formerly AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC), a company with operations in the United States and China focused on early cancer screening and detection and plans...

2023-05-20 00:55 6056

Delivering Superb Performance with "Mn"! Gotion High-Tech's Astroinno Battery Features Range of 1000km without using NCM

* Gotion High-Tech launches the new L600 LMFP Astroinno battery on May 19 * Single-cell energy density of 240Wh/kg, system energy density of 190Wh/kg * NCM-free, range of 1000km, mass production expected in 2024 HEFEI, China, May 19, 2023 /PRNewswire/ -- On May 19, Gotion High-Tech launched i...

2023-05-19 22:49 5953

TDK Ventures launches $150 million Fund EX1 to invest in energy and climate tech startups

* EX in the new fund's name stands for energy transformation, signaling the focus for Fund EX1 on investing in early-stage energy, cleantech, and climate technology startups in the U.S. andEurope * Fund EX1 is TDK Ventures' first multi-LP fund and marks its first foray into Europe SAN JOSE, Ca...

2023-05-19 22:00 6419

Positive Results from Interim Analysis of 'GEN-001' Plus avelumab (Bavencio®) Phase II Trial

* Positive primary endpoint result of objective response rate (ORR) from the planned interim analysis of Phase II trial in advanced gastric/gastroesophageal junction adenocarcinoma (GC/GEJ). * Top-line data of the final analysis from Phase II to be announced in the second half of next year. S...

2023-05-19 21:00 3558

ReTo Eco-Solutions, Inc. Announces $6.6 Million Registered Direct Offering

BEIJING, May 19, 2023 /PRNewswire/ -- ReTo Eco-Solutions, Inc. (Nasdaq: RETO) ("ReTo" or the "Company"), a provider of technology solutions and operation services for intelligent ecological environments and roadside assistance services and software development services inChina, today announced th...

2023-05-19 20:30 5684

XODIAC Tickets Officially Go On Sale: Color Star Invites You To The Live Experience

NEW YORK, May 19, 2023 /PRNewswire/ -- Color Star Technology Co., Ltd. (Nasdaq: ADD) ("Color Star" or the "Company"), an entertainment technology company with a global network that focuses on the application of technology and artificial intelligence in the entertainment industry, recently announc...

2023-05-19 20:30 4327

NetEase Cloud Music Launches Dolby Atmos for Vast Music Contents and Scenarios

HANGZHOU, China, May 19, 2023 /PRNewswire/ -- Cloud Music Inc. (HKEX: 9899, "NetEase Cloud Music" or the "Company"), a leading interactive music streaming service provider inChina, recently announced it now supports Dolby Atmos® across its vast music library and scenarios, making premium immersiv...

2023-05-19 20:00 4746

WiMi Develops A Hybrid Augmented Intelligence System Based on Human-Computer Collaboration

BEIJING, May 19, 2023 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that its R&D team has developed a hybrid augmented intelligence system based on human-computer collabora...

2023-05-19 20:00 3878

Daewoong Pharmaceutical Presents New Clinical Data of Fexuprazan at Digestive Disease Week 2023

-  New investigational data evaluating Fexuprazan in a Korean clinical trial program for healing erosive esophagitis (EE) regardless of food intake, and in a Chinese pivotal clinical trial program for the treatment of EE SEOUL, South Korea and CHICAGO, May 19, 2023 /PRNewswire/ -- Daewoong Pharm...

2023-05-19 20:00 3754

HanAll Biopharma Announces Results from Phase III randomized, double-masked active treatment-controlled VELOS-3 Trial Evaluating Tanfanercept 0.25% for Treatment of Dry Eye Disease

* Tanfanercept did not demonstrate statistical significance in either of the primary outcome measures of improvement in central corneal staining score (CCSS) or in improvement in Eye Dryness Score (EDS) assessed at week 8 in subjects with dry eye disease (DED), compared to vehicle. * However,...

2023-05-19 19:00 2879

Altair's Toggled Survey Reveals Overwhelming Adoption Rates for Smart Building Tech, Significant Headroom Remains for Data Analytics in Facilities Management

78% of businesses have adopted smart building tech to drive energy efficiency, lower costs, decrease carbon emissions, and manage return to work – yet gaps still exist TROY, Mich., May 19, 2023 /PRNewswire/ -- Toggled®, a wholly owned subsidiary ofAltair (Nasdaq: ALTR) focused on intelligent bui...

2023-05-19 19:00 4261

HKEX to Launch HKD-RMB Dual Counter Model on 19 June 2023

* HKD-RMB Dual Counter Model to be launched in Hong Kong securities market on 19 June 2023, subject to market readiness * HKEX now accepting applications for Dual Counter Market Makers HONG KONG, May 19, 2023 /PRNewswire/ -- Hong Kong Exchanges and Clearing Limited (HKEX) is today (Friday) pl...

2023-05-19 18:43 6404

CNFinance to Report First Quarter of 2023 Financial Results on Friday, May 26, 2023

GUANGZHOU, China, May 19, 2023 /PRNewswire/ -- CNFinance Holdings Limited (NYSE: CNF) ("CNFinance" or the "Company"), a leading home equity loan service provider in China, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2023, before U.S. m...

2023-05-19 18:00 4621

LightInTheBox to Report First Quarter 2023 Financial Results on Friday, May 26, 2023

SINGAPORE, May 19, 2023 /PRNewswire/ -- LightInTheBox Holding Co., Ltd. (NYSE: LITB) ("LightInTheBox" or the "Company"), a global online retail company that delivers products directly to consumers around the world, today announced that it will release its unaudited financial results for the first...

2023-05-19 18:00 5083

Appier was awarded the 'Best Talent Acquisition Team'

Appier's talent-driven approach: Empowering growth in the competitive AI market through strong recruitment and retention efforts TAIPEI, May 19, 2023 /PRNewswire/ -- Appier, a leading software-as-a-service (SaaS) company that uses artificial intelligence (AI) to power business decision-making, i...

2023-05-19 17:07 4474

Greenland Technologies Reports First Quarter 2023 Unaudited Financial Results

-  1Q23 Gross Margin Improves 320 Basis Points Year-over-Year -  Cash and Cash Equivalents Rises 125% Year-over-Year to $15.4 Million EAST WINDSOR, N.J., May 19, 2023 /PRNewswire/ -- Greenland Technologies Holding Corporation (NASDAQ: GTEC) ("Greenland" or the "Company"), a technology developer a...

2023-05-19 17:00 5174

Microsoft announces new AI solutions for Microsoft Cloud for Nonprofit: a game-changer for fundraising and volunteer engagement

SINGAPORE, May 19, 2023 /PRNewswire/ -- Microsoft Corp. announced a suite of new AI solutions and improvements toMicrosoft Cloud for Nonprofit  that are designed to transform the nonprofit industry and how fundraisers engag...

2023-05-19 16:38 4402

Improved Overall Health, Better Sleep, and Enhanced Immunity Ranked as Top Three Health Goals by Increasingly Health-Conscious Asia Pacific Consumers - Herbalife Survey

The survey reveals 84% of Asia Pacific Consumers recognize the importance of a support group in helping them achieve health and wellness goals HONG KONG, May 19, 2023 /PRNewswire/ -- Herbalife, a premier health and wellness company and community, today released the findings of its Asia Pacific H...

2023-05-19 16:38 4369

Positive Results from Interim Analysis of 'GEN-001' Plus avelumab (Bavencio®) Phase II Trial

SEOUL, South Korea, May 19, 2023 /PRNewswire/ -- Genome & Company (CEO: Pae, Jisoo), a global leading microbiome therapeutics developer, announced that this phase II trial (NCT05419362) will continue without modifications to move on to the second stage, based on the positive result of the interim...

2023-05-19 16:00 3021